Implantable cardiac stimulation device that minimizes parasitic muscle stimulation and method

• US 7,076,301 B1
• Filed: 12/20/2002
• Issued: 07/11/2006
• Est. Priority Date: 12/20/2002
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Poore, John W., Kroll, Mark W.
• Primary Examiner(s): LAYNO, CARL HERNANDZ
• Application Number:
  US10/326,746
• Time in Patent Office: 1,299 Days
• Field of Search: 607/9, 607/17, 607/19, 607 27- 28
• US Class Current: 607/17
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold

Abstract

An implantable cardiac stimulation device provides capture of a chamber of a heart with pacing pulses while minimizing parasitic muscle tissue stimulation. A parasitic muscle stimulation detector detects if the application of pacing pulses result in parasitic muscle stimulation. If there is parasitic muscle stimulation resulting from the application of pacing pulses, a pulse generator control adjusts the pacing pulse amplitudes and durations until the pacing pulses capture the chamber of the heart without causing parasitic muscle stimulation.

Claims

1. An implantable cardiac stimulation device comprising:

a sensor that is operative to sense a parameter associated with parasitic muscle tissue stimulation;

a pulse generator adapted to provide pacing pulses to a chamber of a heart; and

a control circuit coupled to the sensor and to the pulse generator, and that is operative to adjust one or more parameters of the pacing pulses to control the degree of parasitic muscle tissue stimulation;

wherein the one or more parameters of the pacing pulses comprise at least one of pulse width and pulse amplitude and wherein the control circuit is operative to lengthen the pacing pulse width and decrease the pacing pulse amplitude; and

wherein the control circuit lengthens the pacing pulse width until a capture threshold amplitude is below a parasitic muscle tissue stimulation threshold.

2. The device of claim 1 wherein the control circuit sets the pacing pulse amplitude to an amplitude above a capture threshold and below the parasitic muscle tissue stimulation threshold.

3. The device of claim 2 wherein the control circuit sets the pacing pulse amplitude to an amplitude above the pacing threshold at a given pacing pulse width prior to increasing the pacing pulse widths.

4. An implantable cardiac stimulation device comprising:

a sensor that is operative to sense a parameter associated with parasitic muscle tissue stimulation;

a pulse generator adapted to provide pacing pulses to a chamber of a heart; and

a control circuit coupled to the sensor and to the pulse generator, and that is operative to adjust one or more parameters of the pacing pulses to control the degree of parasitic muscle tissue stimulation;

wherein the one or more parameters of the pacing pulses comprise at least one of pulse width and pulse amplitude and wherein the control circuit is operative to lengthen the pacing pulse width and decrease the pacing pulse amplitude; and

wherein the control circuit further comprises a pulse generator control to lengthen the pacing pulse width and to decrease the pacing pulse amplitude until the pacing pulses fail to both capture the chamber and stimulate parasitic muscle tissue, then to increase the pacing pulse amplitude while maintaining the pacing pulse widths substantially constant until the pacing pulses both capture the chamber and stimulate parasitic muscle tissue, and then to lengthen the pacing pulse width while decreasing the pacing pulse amplitude until a pacing pulse captures the chamber and fails to stimulate parasitic muscle tissue.

5. An implantable cardiac stimulation device comprising:

a sensor that is operative to sense a parameter associated with parasitic muscle tissue stimulation;

a pulse generator adapted to provide pacing pulses to a chamber of a heart;

a control circuit coupled to the sensor and to the pulse generator, and that is operative to adjust one or more parameters of the pacing pulses to control the degree of parasitic muscle tissue stimulation; and

a lead system adapted to be coupled to the pulse generator and having at least one electrode that provides the pacing pulses to a left ventricle.

6. An implantable cardiac stimulation device comprising:

means for detecting parasitic muscle tissue stimulation;

pulse generator means for providing pacing pulses to a chamber of a heart of a patient; and

control means for adjusting one or more parameters of the pacing pulses to control the degree of parasitic muscle tissue stimulation;

wherein the control means comprises means for lengthening the pacing pulse width until a capture threshold amplitude is below a parasitic muscle tissue stimulation threshold.

7. The device of claim 6 wherein the control means comprises means for setting the pacing pulse amplitude to an amplitude above the capture threshold amplitude and below the parasitic muscle tissue stimulation threshold.

8. The device of claim 6 wherein the control means comprises means for setting the pacing pulse amplitude to an amplitude above the capture threshold at a given pacing pulse width prior to increasing the pacing pulse widths.

9. An implantable cardiac stimulation device comprising:

means for detecting parasitic muscle tissue stimulation;

pulse generator means for providing pacing pulses to a chamber of a heart of a patient;

control means for adjusting one or more parameters of the pacing pulses to control the degree of parasitic muscle tissue stimulation; and

lead means adapted to be coupled to the pulse generator and providing the pacing pulses to a left ventricle.

10. The device of claim 9 wherein the one or more parameters of the pacing pulses include pulse width and pulse amplitude and wherein the control means includes means for lengthening the pacing pulse width and decreasing the pacing pulse amplitude.

11. In an implantable cardiac stimulation device, a method comprising:

applying pacing pulses to a chamber of a heart of a patient;

detecting parasitic muscle tissue stimulation in response to the pacing pulses; and

adjusting one or more parameters of the pacing pulses to control the degree of parasitic muscle tissue stimulation;

wherein the one or more parameters of the pacing pulses comprise at least one of pulse width and pulse amplitude, and wherein adjusting one or more parameters comprises lengthening the pacing pulse width and decreasing the pacing pulse amplitude.

12. The method of claim 11 wherein lengthening the pacing pulse width comprises lengthening the pacing pulse width until a capture threshold is below a parasitic muscle tissue stimulation threshold.

13. The method of claim 12 wherein adjusting comprises setting the pacing pulse amplitude to an amplitude above the capture threshold and below the parasitic muscle tissue stimulation threshold.

14. A cardiac stimulation device comprising:

a pulse generator that applies stimulation pulses to a chamber of a heart of a patient;

a sensor that senses parasitic muscle activity of the patient following one of the stimulation pulses, and that provides a corresponding activity signal; and

a parasitic muscle tissue stimulation detector that processes the activity signal and detects parasitic muscle tissue stimulation resulting from the stimulation pulses.

15. The device of claim 14 wherein the sensor comprises an accelerometer.

16. In a cardiac stimulation device, a method comprising:

applying stimulation pulses to a chamber of a heart;

sensing parasitic muscle activity of the patient following at least one of the stimulation pulses, and providing a corresponding activity signal; and

detecting parasitic muscle tissue stimulation resulting from the stimulation pulses based on the activity signal.